Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Shyam M. Srinivas, MD, PhD, is an Associate Staff member in the Nuclear Medicine Department at Cleveland Clinic. He completed his residency training in nuclear medicine at the University of Pennsylvania in Philadelphia, after a preliminary year of internal medicine internship at Christiana Care in Newark, Del. He is board-certified by both the American Board of Nuclear Medicine and the Certification Board of Nuclear Cardiology.
Dr. Srinivas graduated from the University of California, Irvine, where he simultaneously pursued an MD and PhD in an NIH-sponsored Medical Scientist Training Program. The purpose of such a program is to produce physician scientists who can directly apply basic science to the medical field and further the art of medicine through research. His PhD was granted from the Department of Electrical Engineering specializing in biomedical optics at the Beckman Laser Institute at UC Irvine, while working on a new optical imaging technique known as optical coherence tomography.
With a background in optical imaging, a transition to nuclear medicine and molecular imaging was natural for Dr. Srinivas. His major research interests are to continue to explore the potential benefits of hypoxia imaging both in cardiac and oncologic applications. He has interests in using combined PET/CT imaging to guide radiation therapy planning, as well as development of new novel radiotracers. With his engineering background, he also has a keen interest in instrumentation and device development and has helped validate the clinical use of a prototype dedicated breast PET scanner.
Dr. Srinivas helped co-found and co-directs the Center for PET and Molecular Imaging at Cleveland Clinic.
cardiac PET, hypoxia imaging, breast cancer detection, optical imaging, instrumentation, and PET/CT for radiation therapy planning
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/12/2014, Dr. Srinivas has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.